Yep, i totally understand and agree it is background noise in the face of the advantages the vaccines offer. That's why, in the post you replied to, i highlighted the rarity of the cases so far
My posting of articles as that is simply meant to give notice to what's happening in other countries, and also as a preemptive against possible anti-vaccination efforts of trolls here.
An earlier post
Should You Be Concerned About Blood Clots, Bleeding and the AZ-Vaccine? "AstraZeneca Concerns Throw Europe’s Vaccine Rollout Into Deeper Disarray" There is no evidence so far of a link between the AstraZeneca shots and a few new cases in Europe of serious illness and deaths. But investigations are underway. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162581919
Dr Norman Swan on the AstraZeneca vaccine and blood clotting reports | ABC News •Apr 2, 2021
ABC News (Australia)
Authorities are investigating a "probable" case of a rare clotting disorder in a 44-year-old Australian man who received the AstraZeneca vaccine and is now being treated at Melbourne's Box Hill Hospital.
Coronacast host Dr Norman Swan told ABC News the man "fits the description of vaccine-induced pro-thrombotic thrombocytopenia".
Blood-clotting case in Australian AstraZeneca vaccine recipient being taken 'very seriously' by Therapeutic Goods Administration
Posted Yesterday at 12:47pm, updated 12hours ago
VIDEO - 5 minutes 45 seconds - Dr Norman Swan says health authorities are closely examining the blood-clotting case in Melbourne.
Australia's Acting Chief Medical Officer Michael Kidd has confirmed authorities are investigating a "probable" case of a rare clotting disorder in an Australian man who received the AstraZeneca vaccine.
Key points:
* It is not clear whether the clots are linked to the man receiving the vaccine
* The Therapeutic Goods Administration says there is no proven link between the AstraZeneca jab and blood clots
* The majority of Australians will receive a dose of the AstraZeneca vaccine, which is being manufactured in Melbourne
Professor Kidd said the matter was being taken "very seriously" and was being investigated by the Therapeutic Goods Administration (TGA).
The TGA's vaccine safety investigation group will meet on Saturday and will seek to determine whether the disorder is linked to the AstraZeneca vaccine.
The blood clots were recorded in a 44-year-old man who is now being treated in Melbourne's Box Hill Hospital.
The man received the AstraZeneca vaccine on or around March 22 and was admitted to hospital with serious thrombosis and a low platelet count.
"He had low platelets, but he had clots in his liver, in his spleen and in his gut in general," Coronacast host Dr Norman Swan told ABC News.
"So, he fits the description of vaccine-induced pro-thrombotic thrombocytopenia. He fits the case description."
Professor Kidd said medical officials were taking the case very seriously.
"This case is currently being investigated by the TGA and a meeting will be held tomorrow morning … which will examine this report and determine whether it could be linked to the AstraZeneca vaccine," he said.
The Acting Chief Medical Officer said investigators had not yet confirmed a "causal link" with the vaccine.
[...]
"If you received the AstraZeneca vaccine and experience symptoms of persistent headaches or other worrying symptoms four to 20 days after the vaccine, you should seek medical advice."
Professor Kidd said anyone getting vaccinated in coming days should bear in mind that clotting disorders were "extremely rare" and had only been reported in a small number of cases.
"The serious risk disease and death from COVID-19, if we experience another severe outbreak, … is far greater than the very small potential risk of a very rare clotting disorder associated with the vaccine," he said.
[...]
"What they found was there was definitely no overall risk of clotting throughout the community that was given the vaccine," he said.
"And that the risk was so low, the benefits of the vaccine would far outweigh any potential risk.
"But they were still looking at this little group where you have this very rare occurrence.
"The rate was somewhere in the order of one in maybe several hundred thousand to one in a million or so.
News 
Market Data 
Discover 
